{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_9", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "de informati on on disease- associated maternal and/or embryo/fetal risk, dose \nadjustments during pregnancy and the postpartum period, maternal adverse reactions, and \nfetal/neonatal adverse reactions.  Information on the effects of the drug on labor or delivery is also \nplaced under this heading.  The data supporting the risk summary are summarized under the Data \nheading of the new Pregnancy subsection. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nPAGE 2 \n3. The Nursing Mothers subsection was renamed the L"}